No abstract
Future Cardiol. 2025 Dec 12:1-9. doi: 10.1080/14796678.2025.2591426. Online ahead of print.
NO ABSTRACT
PMID:41384357 | DOI:10.1080/14796678.2025.2591426
A plain language review of the ATTRibute-CM study: efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy
Scritto il 12/12/2025
da Julian D Gillmore